XML 51 R42.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Entities and Acquisitions - Pro Forma Information (Details) - Entasis Therapeutics Holdings Inc - La Jolla Pharmaceutical Company - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2022
Business Acquisition [Line Items]    
Revenue $ 72,830 $ 292,077
Net income 223,082 273,301
Net income attributable to Innoviva stockholders $ (274,407) $ 282,704